Kong Fanming: Clinical Trials

4 trials sponsored by Kong Fanming, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 3 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 3
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Kong Fanming: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC
Electroacupuncture (EA), Sham electroacupuncture - Non-Small Cell Lung Cancer, Electroacupuncture
Not applicableRecruitingKong Fanming1202025-11-302025-11-20
Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
Electroacupuncture (EA), Sham electroacupuncture - Elderly Patients (>65 Years), Non-Small Cell Lung Cancer
Not applicableRecruitingKong Fanming1202025-07-082025-07-25
Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
Electroacupuncture combined with immunotherapy, Zilongjin tablet combined with immunotherapy, Immunotherapy - Non-Small Cell Lung Cancer, Electroacupuncture
Phase 2 / Phase 3RecruitingKong Fanming4052025-01-012025-06-24
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Transcutaneous Acupoint Electrical Stimulation (TAES) - Postoperative Cough, Lung Cancer
Not applicableRecruitingKong Fanming842024-04-172025-09-08

Conditions studied

Carcinoma, Non-Small-Cell Lung (3)  ·  Lung Neoplasms (1)

Interventions

Electroacupuncture (2)  ·  Immunotherapy (1)

Countries

China (4)